Curaleaf (OTCMKTS:CURLF) Announces Quarterly Earnings Results

Curaleaf (OTCMKTS:CURLF) announced its earnings results on Wednesday. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.01), Zacks reports. The company had revenue of $342.29 million for the quarter, compared to analyst estimates of $344.57 million. Curaleaf had a negative return on equity of 14.43% and a negative net margin of 20.29%.

Curaleaf Stock Down 3.5 %

CURLF traded down $0.12 during midday trading on Friday, reaching $3.26. 269,728 shares of the company were exchanged, compared to its average volume of 764,632. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.36 and a current ratio of 0.72. The company’s fifty day moving average price is $4.02 and its 200 day moving average price is $4.72. The company has a market cap of $2.11 billion, a price-to-earnings ratio of -8.36 and a beta of 0.88. Curaleaf has a one year low of $2.51 and a one year high of $6.40.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reissued a “buy” rating and issued a $6.25 price objective on shares of Curaleaf in a research note on Thursday.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.